Standout Papers
Immediate Impact
35 standout
Citing Papers
Tirzepatide for Heart Failure with Preserved Ejection Fraction and Obesity
2024 Standout
Effects of semaglutide with and without concomitant SGLT2 inhibitor use in participants with type 2 diabetes and chronic kidney disease in the FLOW trial
2024 Standout
Works of Pau Llàcer being referenced
Effect of β-Blocker Withdrawal on Functional Capacity in Heart Failure and Preserved Ejection Fraction
2021 Standout
Comorbidities and their implications in patients with and without type 2 diabetes mellitus and heart failure with preserved ejection fraction. Findings from the rica registry
2020
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Pau Llàcer | 637 | 139 | 93 | 93 | 84 | 786 | |
| Nikola Kozhuharov | 713 | 114 | 45 | 92 | 59 | 856 | |
| Zehra Buğra | 550 | 108 | 70 | 219 | 62 | 870 | |
| Anna Mollar | 673 | 180 | 108 | 125 | 62 | 900 | |
| Colette E. Jackson | 526 | 168 | 74 | 119 | 38 | 776 | |
| Tomoya Ueda | 515 | 163 | 73 | 245 | 79 | 785 | |
| Gunnar Plehn | 735 | 132 | 73 | 139 | 65 | 918 | |
| B. E. Strauer | 700 | 115 | 62 | 152 | 83 | 901 | |
| Matteo Serenelli | 432 | 92 | 147 | 132 | 41 | 658 | |
| Giuseppe Dattilo | 427 | 135 | 49 | 83 | 82 | 714 | |
| Taku Nishida | 483 | 117 | 46 | 187 | 59 | 811 |
All Works
Login with ORCID to disown or claim papers
Loading papers...